Literature DB >> 26286840

Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed.

Margaret Haney1, A Eden Evins2.   

Abstract

There have been extensive policy shifts in the legality of recreational and therapeutic use of cannabis in the United States, as well as a steady increase in the number of people using the drug on a regular basis. Given these rapid societal changes, defining what is known scientifically about the consequences of cannabis use on mental health takes on added public health significance. The purpose of this circumspectives piece is to discuss evidence of cannabis' effects on two psychiatric conditions: post-traumatic stress disorder and psychotic disorders. Dr Haney and Dr Evins will discuss two viewpoints regarding the benefit and harm of cannabis use for these conditions, while outlining what remains unproven and requires further testing to move the field forward.

Entities:  

Mesh:

Year:  2015        PMID: 26286840      PMCID: PMC5130141          DOI: 10.1038/npp.2015.251

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  110 in total

1.  Cannabis use correlates with schizotypal personality traits in healthy students.

Authors:  Patrick Dumas; Mohamed Saoud; Sébastien Bouafia; Christel Gutknecht; René Ecochard; Jean Daléry; Thierry Rochet; Thierry d'Amato
Journal:  Psychiatry Res       Date:  2002-01-31       Impact factor: 3.222

2.  Testing hypotheses about the relationship between cannabis use and psychosis.

Authors:  Louisa Degenhardt; Wayne Hall; Michael Lynskey
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

Review 3.  The association between regular cannabis exposure and alterations of human brain morphology: an updated review of the literature.

Authors:  Valentina Lorenzetti; Nadia Solowij; Alex Fornito; Dan Ian Lubman; Murat Yucel
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization.

Authors:  Daniel J Foti; Roman Kotov; Lin T Guey; Evelyn J Bromet
Journal:  Am J Psychiatry       Date:  2010-05-17       Impact factor: 18.112

5.  Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.

Authors:  Deepak Cyril D'Souza; Walid Michel Abi-Saab; Steven Madonick; Kimberlee Forselius-Bielen; Anne Doersch; Gabriel Braley; Ralitza Gueorguieva; Thomas B Cooper; John Harrison Krystal
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

6.  The impact of substance use at psychosis onset on First Episode Psychosis course: results from a 1 year follow-up study in Bologna.

Authors:  Ilaria Tarricone; Jane Boydell; Serena Panigada; Fabio Allegri; Thomas Marcacci; Maria Gabriella Minenna; Arnisa Kokona; Federico Triolo; Viviana Storbini; Rossella Michetti; Craig Morgan; Marta Di Forti; Robin M Murray; Domenico Berardi
Journal:  Schizophr Res       Date:  2014-02-11       Impact factor: 4.939

Review 7.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

8.  Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.

Authors:  Paolo Fusar-Poli; José A Crippa; Sagnik Bhattacharyya; Stefan J Borgwardt; Paul Allen; Rocio Martin-Santos; Marc Seal; Simon A Surguladze; Colin O'Carrol; Zerrin Atakan; Antonio W Zuardi; Philip K McGuire
Journal:  Arch Gen Psychiatry       Date:  2009-01

Review 9.  Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.

Authors:  G W Dalack; D J Healy; J H Meador-Woodruff
Journal:  Am J Psychiatry       Date:  1998-11       Impact factor: 18.112

10.  Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.

Authors:  A Neumeister; M D Normandin; R H Pietrzak; D Piomelli; M Q Zheng; A Gujarro-Anton; M N Potenza; C R Bailey; S F Lin; S Najafzadeh; J Ropchan; S Henry; S Corsi-Travali; R E Carson; Y Huang
Journal:  Mol Psychiatry       Date:  2013-05-14       Impact factor: 15.992

View more
  23 in total

1.  Circumspectives: Cannabis and Psychiatric Illness: Blunt Thoughts.

Authors:  Markus Heilig; William A Carlezon
Journal:  Neuropsychopharmacology       Date:  2015-11-11       Impact factor: 7.853

2.  Cannabis and Mental Health: Insights from Canadian Research.

Authors:  Rebecca Haines-Saah
Journal:  Can J Psychiatry       Date:  2019-05       Impact factor: 4.356

Review 3.  Cannabis regulatory science: risk-benefit considerations for mental disorders.

Authors:  Jacob T Borodovsky; Alan J Budney
Journal:  Int Rev Psychiatry       Date:  2018-05-29

4.  Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study.

Authors:  Nehal P Vadhan; Cheryl M Corcoran; Gill Bedi; John G Keilp; Margaret Haney
Journal:  Psychiatry Res       Date:  2017-08-01       Impact factor: 3.222

5.  Cannabis use disorder and male sex predict medical cannabis card status in a sample of high risk adolescents.

Authors:  Janet Kim; Marilyn E Coors; Susan E Young; Kristen M Raymond; Christian J Hopfer; Tamara L Wall; Robin P Corley; Sandra A Brown; Joseph T Sakai
Journal:  Drug Alcohol Depend       Date:  2017-12-02       Impact factor: 4.492

Review 6.  Medical Marijuana and Marijuana Legalization.

Authors:  Rosalie Liccardo Pacula; Rosanna Smart
Journal:  Annu Rev Clin Psychol       Date:  2017-05-08       Impact factor: 18.561

7.  State medical marijuana laws, cannabis use and cannabis use disorder among adults with elevated psychological distress.

Authors:  Ryan K McBain; Eunice C Wong; Joshua Breslau; Amy L Shearer; Matthew S Cefalu; Elizabeth Roth; M Audrey Burnam; Rebecca L Collins
Journal:  Drug Alcohol Depend       Date:  2020-07-24       Impact factor: 4.492

Review 8.  Affect and cannabis use in daily life: a review and recommendations for future research.

Authors:  Andrea M Wycoff; Jane Metrik; Timothy J Trull
Journal:  Drug Alcohol Depend       Date:  2018-08-15       Impact factor: 4.492

9.  Older, Less Regulated Medical Marijuana Programs Have Much Greater Enrollment Rates Than Newer 'Medicalized' Programs.

Authors:  Arthur Robin Williams; Mark Olfson; June H Kim; Silvia S Martins; Herbert D Kleber
Journal:  Health Aff (Millwood)       Date:  2016-03       Impact factor: 6.301

10.  30 Years on: How the Neurodevelopmental Hypothesis of Schizophrenia Morphed Into the Developmental Risk Factor Model of Psychosis.

Authors:  Robin M Murray; Vishal Bhavsar; Giada Tripoli; Oliver Howes
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.